SS Innovations International has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $1 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, SS Innovations International is raising $1,000,000.00 in new funding. About SS Innovations International: SS Innovations International Inc. is a leading medical technology company founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon. Dr. Srivastava, serving as the founder, chairman, and CEO, has revolutionized the field of cardiothoracic surgery through his pioneering work in robotic procedures. He holds the record for the most number of robotic Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) surgeries. His visionary approach led to the development of the groundbreaking surgical robotic system, the SSi Mantra. This innovative technology aims to transform the landscape of robotic surgery by making advanced, affordable, and accessible surgical procedures available to underserved populations worldwide by decentralizing excellence. SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
To learn more about SS Innovations International, visit http://ssinnovations.com/
Contact:
Sudhir Srivastava, Chief Executive Officer
954-478-1410
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.